Form 8-K · Current report

ResMed| 8-K, filed Aug 17, 2026

Filed
CIK
0000943819
Accession no.
0001193125-26-354154
AI-generated summary

Summary

ResMed dismissed KPMG as its independent registered public accounting firm effective Aug. 13, 2026, and appointed PricewaterhouseCoopers to the role for the fiscal year ending June 30, 2027, subject to PricewaterhouseCoopers’ standard client acceptance procedures. ResMed director Ron Taylor will not stand for election at the 2026 annual meeting, expected Nov. 18, 2026, and intends to retire then; the board appointed Carol Burt as lead director effective Nov. 15, 2026.

Key points

  • KPMG was dismissed as ResMed’s principal accountant effective Aug. 13, 2026; its reports for fiscal years ended June 30, 2026 and 2025 had no adverse opinion, disclaimer, or qualification, and no disagreements or reportable events were disclosed.
  • The Audit Committee appointed PricewaterhouseCoopers as independent registered public accounting firm for the fiscal year ending June 30, 2027, subject to completion of PwC’s standard client acceptance procedures.
  • Ron Taylor, a ResMed director since 2005 and lead director since 2013, will not stand for reelection at the 2026 annual meeting and will retire after more than 21 years of service.
  • Carol Burt, a ResMed director since 2013 and chair of the Nominating and Governance Committee, will become lead director on Nov. 15, 2026.

Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.

Items reported

  • 4.01Changes in Registrant's Certifying Accountant
  • 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 7.01Regulation FD Disclosure
  • 9.01Financial Statements and Exhibits

From the filing

Item 4.01. Changes in the Registrant’s Certifying Accountant. (a) Dismissal of Previous Independent Registered Public Accounting Firm KPMG LLP (“KPMG”) was previously the principal accountants for ResMed Inc. (the “Company” or “Resmed”). On August 13, 2026, KPMG was dismissed, effective as of that date. The reports of KPMG on the Company’s consolidated financial statements for the fiscal years ended June 30, 2026 and 2025 did not contain any adverse opinion or disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope, or accounting principles. …

An excerpt of the text as filed with the SEC, cut for length.

Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.

Follow ResMed| in Readster

Add ResMed| to your watchlist and its SEC filings reach your brief alongside the news about it, every line cited to its source. Readster also follows topics, people, newsletters and podcasts.

No credit card. When the trial ends, you move to Readster Free unless you subscribe.